BIOMAT Database Logo BIOMAT Database Logo

Optimising a limiting dilution culture system for quantitating frequencies of alloreactive cytotoxic T lymphocyte precursors. 1991

E Kaminski, and J Hows, and J Goldman, and R Batchelor
Department of Immunology, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom.

We have developed a limiting dilution assay for estimating the frequencies of allo-MHC reactive cytotoxic T lymphocyte precursors (CTL-p) in peripheral blood. The culture conditions were optimised in order to give maximum sensitivity while at the same time maintaining a high degree of specificity. While the addition of filler cells, interleukin-1 and interleukin-4 were unnecessary, the addition of interleukin-2 (IL-2) was crucial for optimal expansion of the CTL-ps. However, excess exogenous IL-2 was found to give rise to nonspecific cytotoxicity, and 5 U/ml final concentration of recombinant IL-2 added on Days 3 and 6 was optimal. The establishment of baseline control cultures for determining positivity and negativity of the test cultures is discussed. Using this modified assay system, we demonstrated that the culture conditions fulfil "single hit" criteria and that the assay is highly specific.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

E Kaminski, and J Hows, and J Goldman, and R Batchelor
Human cytotoxic T lymphocytes. I. Limiting-dilution analysis of alloreactive cytotoxic T-lymphocyte precursor frequencies.
September 1985, Scandinavian journal of immunology,
E Kaminski, and J Hows, and J Goldman, and R Batchelor
Limiting dilution analysis of alloreactive T helper cells: precursor frequencies similar to that of alloreactive cytotoxic T cells.
February 1983, Immunobiology,
E Kaminski, and J Hows, and J Goldman, and R Batchelor
Frequencies of alloreactive cytotoxic T-lymphocyte precursors responding to H-2 antigens alone.
June 1980, Immunology,
E Kaminski, and J Hows, and J Goldman, and R Batchelor
Enumeration of human alloreactive helper T lymphocyte precursor frequencies by limiting dilution analysis of interleukin-2 production.
September 1996, Journal of immunological methods,
E Kaminski, and J Hows, and J Goldman, and R Batchelor
Limiting dilution analysis of primary cytotoxic T-cell precursors.
October 1997, Journal of immunological methods,
E Kaminski, and J Hows, and J Goldman, and R Batchelor
Specific depletion of alloreactive cytotoxic lymphocyte precursors.
May 1979, Nature,
E Kaminski, and J Hows, and J Goldman, and R Batchelor
Human cytotoxic T lymphocytes. II. Frequency analysis of cyclosporin A-sensitive alloreactive cytotoxic T-lymphocyte precursors.
May 1987, Immunology,
E Kaminski, and J Hows, and J Goldman, and R Batchelor
Optimizing a limiting dilution culture system for quantifying the frequency of interleukin-2-producing alloreactive T helper lymphocytes.
August 1997, Transplantation,
E Kaminski, and J Hows, and J Goldman, and R Batchelor
A rapid limiting dilution assay for measuring frequencies of alloreactive, interleukin-2-producing T cells in humans.
February 1992, Journal of immunological methods,
E Kaminski, and J Hows, and J Goldman, and R Batchelor
Frequencies of alloreactive and self-restricted cytotoxic T cell precursors during lymphatic regeneration.
August 1983, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!